Intrinsic Value of S&P & Nasdaq Contact Us

eXoZymes, Inc. EXOZ NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
36/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

There have been 6 recent insider transactions recorded for eXoZymes, Inc. (EXOZ), including 5 buys and 0 sells. Total insider buying was valued at $3.05M and total insider selling at RSU Award.

Notable insiders with recent activity include Heltzen Michael, Korman Tyler Paz, Nawaz Fouad. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — EXOZ

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2025-07-02 Heltzen Michael Chief Executive Officer Informative Buy 1,040 $10.22 $10.63K 10,629
2025-06-17 Heltzen Michael Chief Executive Officer RSU Award 235,817 $12.40 $2.92M 235,817
2025-06-16 Korman Tyler Paz Vice President, Research RSU Award 2,990 $12.54 $37.49K 725,291
2025-06-13 Nawaz Fouad Vice President, Finance RSU Award 3,489 $12.54 $43.75K 3,489
2025-06-13 Opgenorth Paul Hideo Vice President, Development RSU Award 2,990 $12.54 $37.49K 641,150
2025-02-17 Rayo Edgardo Javier Director Unknown - - - 77,909
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message